---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-135895"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T04:13:19.342144+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences regains compliance with Nasdaq stockholders' equity requirement

## Summary
- Reported stockholders' equity of $2.67M as of Sep 30, 2024, meeting the $2.5M minimum.
- Entered warrant inducement letters on Dec 3, 2024; 4,064,040 warrants exercised at $1.00/share.
- Gross proceeds from warrant exercises approximately $4.1M; equity now ~$6.0M, cash ~$7.1M.
- Company believes it is compliant with Nasdaq Listing Rule 5550(b)(1) as of Dec 12, 2024.

## SEC filing metadata
- accession: 0000950170-24-135895
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017024135895/0000950170-24-135895-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024135895/revb-20241212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-135895
- JSON: https://secwatch.observer/filing/0000950170-24-135895.json
- Plain text: https://secwatch.observer/filing/0000950170-24-135895.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.